The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.30
Bid: 12.00
Ask: 14.00
Change: 0.50 (4.00%)
Spread: 2.00 (16.667%)
Open: 13.90
High: 14.00
Low: 13.30
Prev. Close: 12.50
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

11 Feb 2010 07:00

RNS Number : 9785G
Carclo plc
11 February 2010
 



11 February 2010

 

Carclo plc

("Carclo" or "the group")

 

Interim Management Statement

 

The board of Carclo is pleased to confirm that trading in the second half of the financial year is continuing in line with its expectations. Divisional operating profits should be well ahead of the first half and underlying profits for the full year are expected to be at a broadly similar level to last year. The Technical Plastics division continues to perform well and win new business in medical and optical. In Precision Products, demand in our aerospace businesses remains subdued but Wipac is seeing a stronger second half, benefitting from its supercar lighting programmes.

 

In December 2009 Carclo and Conductive Inkjet Technology ("CIT") announced that an agreement had been signed with Atmel Corporation ("Atmel") for the development and launch of an innovative touch screen product based on CIT's patented photolithographic film. CIT is on track to install a production line in its Cambridge facility for the manufacture of touch screen sensors which should be operational by the end of this calendar year. Atmel has made a payment to CIT of $0.5 million to secure preferential access to CIT's capacity with further payments of up to $0.5 million due once the production line is installed and commissioned.

 

Since the half year results were announced, the group has raised £3.5 million in cash, net of costs, through a placing of 2,858,000 new Carclo shares. This 5% placing was achieved at a nil discount to the prevailing mid market price and the funds are being used to accelerate a number of growth opportunities, primarily at CIT. This fundraising will enable the group to continue to reduce debt levels whilst investing in its growth businesses.

 

The group's finances remain strong, its main businesses continue to demonstrate their underlying strengths and CIT is now commercialising rapidly. The board is confident of delivering further progress in the next financial year.

 

- ENDS -

 

 

Enquiries:

 

 

 

Carclo plc

01924 268040

Ian Williamson, Chief Executive

 

Robert Brooksbank, Finance Director

 

 

 

Weber Shandwick Financial

 020 7067 0700

Terry Garrett / Stephanie Badjonat / Clare Thomas

 

 

Notes to editors

 

·; Carclo plc is a global supplier of technical plastic components. It is a public company whose shares are quoted on the London Stock Exchange.

 

·; Two thirds of sales are derived from the supply of fine tolerance, injection moulded plastic components, which are used in medical, optical and electronics products. This business, Carclo Technical Plastics, operates internationally in a fast growing and dynamic market underpinned by rapid technological development.

 

·; One third of sales are derived from the supply of specialised precision products to the premium automotive and aerospace industries.

 

·; Carclo's strategy is to develop new technologies and products to drive future growth.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSGGUAAPUPUGQU
Date   Source Headline
30th Apr 20247:00 amRNSHolding(s) in Company
30th Apr 20247:00 amRNSHolding(s) in Company
26th Apr 20247:00 amRNSTrading Statement
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.